Of 16,732 patients with metastatic prostate cancer who died after being diagnosed between 2000 and 2016, nearly 17 percent died from other causes, according to a study published Aug. 5 in JAMA Network ...
3don MSN
Easy-to-use tool can identify high- and low-risk metastatic prostate cancer patients earlier
A new study published in Nature Communications provides a framework for researching whether earlier, model-guided treatment ...
A large-scale study has identified dozens of blood proteins linked to prostate cancer risk, some shared across populations, ...
A newly published study involving researchers from Karolinska Institutet indicates that prostate cancer can be diagnosed at an early stage through a simple urine sample. With the aid of AI and ...
Men treated for nonmetastatic prostate cancer under current guidelines are up to 6 times less likely to die from their cancer than from other causes, according to data from a Swedish cancer registry.
While prostate cancer recurrence is a major cause of death in patients receiving localized treatment, there are other significant causes of mortality. While prostate cancer progression or recurrence ...
A large national and international study has identified dozens of blood proteins linked to prostate cancer risk, some shared across populations, some unique to specific groups. Published in Nature ...
Wenlong Carl Chen receives funding from the National Research Foundation of South Africa and the National Institute of Health (USA). A breakthrough study has identified the genetic risk factors that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results